Home > Financial Ratios > BAL PHARMA

BAL PHARMA
Core EBITDA Growth

    Back to All Ratios
BAL PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BAL PHARMA
Please provide your vote to see the results

BAL PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -5.3928.99-10.0912.99274.74

What is the latest Core EBITDA Growth ratio of BAL PHARMA ?

The latest Core EBITDA Growth ratio of BAL PHARMA is -5.39 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025-5.39
Mar202428.99
Mar2023-10.09
Mar202212.99
Mar2021274.74

How is Core EBITDA Growth of BAL PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 -5.39
Negative
Mar2024 28.99
Positive
Mar2023 -10.09
Negative
Mar2022 12.99
-95.27
Mar2021 274.74 -

Other Financial Ratios of BAL PHARMA


Compare Core EBITDA Growth ratio of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹122.7 Cr 1.4% 16% -28.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹399,549.0 Cr -1.9% -7.3% -2.2% Stock Analytics
DIVIS LABORATORIES ₹166,862.0 Cr 1.8% 3.3% 9.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹139,912.0 Cr -0.5% -4% 29.9% Stock Analytics
DR REDDYS LABORATORIES ₹101,891.0 Cr 0.2% -4.9% 6.6% Stock Analytics
CIPLA ₹99,591.5 Cr 0.5% -3.8% -17% Stock Analytics


BAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

1.4%

16%

-28.5%

SENSEX

3.2%

5%

5.5%


You may also like the below Video Courses